Publicacións en colaboración con investigadores/as de KU Leuven (113)

2024

  1. Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains

    Journal of Endocrinological Investigation, Vol. 47, Núm. 4, pp. 1005-1014

  2. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

    Aging Male, Vol. 27, Núm. 1

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Does testosterone influence the association between sleep and frailty in men: results from the European Male Aging Study

    BMC Geriatrics, Vol. 23, Núm. 1

  3. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  4. Number of CAG repeats and mortality in middle aged and older men

    Clinical Endocrinology, Vol. 99, Núm. 6, pp. 559-565

  5. Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 3, pp. 1520-1532

2022

  1. Aging Men With Insufficient Vitamin D Have a Higher Mortality Risk: No Added Value of its Free Fractions or Active Form

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 3, pp. e1212-e1220

  2. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort

    Andrology, Vol. 10, Núm. 7, pp. 1328-1338

  3. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520

  4. Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status

    Age and ageing, Vol. 51, Núm. 4

  5. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

    Physiology and Behavior, Vol. 252

  6. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort

    Frontiers in Endocrinology, Vol. 13

2021

  1. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10

  2. Empagliflozin in heart failure with a preserved ejection fraction

    New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461

  3. Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 6, pp. 1818-1831

  4. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

  5. Placebo effects in allergen immunotherapy—An EAACI Task Force Position Paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 629-647

  6. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  7. Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates: Results From the European Male Ageing Study

    Journal of Sexual Medicine, Vol. 18, Núm. 5, pp. 908-919